1, 2, 3-triazole-dithiocarbamate-naphthalimides: Synthesis, characterization, and biological evaluation. Issue 3 (March 2021)

• Record Type: Journal Article
• Authors: Chen, Qiu Mei; Li, Zhen; Tian, Guang Xun; Chen, Yi; Wu, Xiang Hua
• Is Part Of: Journal of chemical research. Volume 45:Issue 3/4(2021)
• Page Start: 258
• Page End: 264
• Publication Date: 2021-03
• Subjects: 1, 2, 3-triazole -- anticancer -- antimicrobial -- dithiocarbamates -- naphthalimide; Chemistry -- Research -- Periodicals; Chemistry -- Periodicals; 540.5
• DOI: 10.1177/1747519820966971
• Languages: English
• ISSNs: 1747-5198

Abstract

Fifteen novel dithiocarbamate-derived naphthalimides as a type of potential anticancer and antimicrobial agents were synthesized and characterized by spectral and analytical techniques. The structures of2b, 5a, and7b were established by X-ray crystallography. Their in vitro antitumor activities were evaluated by the MTT method against MDA-MB-231, HepG-2, PC12, as well as A549. Based on the results of the MTT assay, compound7c bearing a morpholinyl substituent displayed the highest activity and selectivity toward HepG-2 cancer cells with an IC50 of 10.86 µM. All new compounds were screened for their antimicrobial activity against Candida albicans, Escherichia coli, Bacillus subtilis, and Staphylococcus aureus . The preliminary results showed that compound7d (an N -methyl piperazine) showed high efficacy against B. subtilis with a minimum inhibitory concentration value of 7.6 µM, which was superior to that of the clinical drug, Cefuroxim. It is found that the anticancer and antibacterial activities of the dithiocarbamate-naphthalimide derivatives were significantly enhanced when bearing a 1, 2, 3-triazole group.